| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/17/2009 | US20090232883 Method of separating vesicle, process for producing medicinal preparation, and method of evaluation |
| 09/17/2009 | US20090232882 PEPTIDE BASED INHIBITION OF caPCNA INTERACTION IN CANCER |
| 09/17/2009 | US20090232881 Enhanced Delivery of Skin Benefit Agents |
| 09/17/2009 | US20090232880 Analogue Compounds Of Archaebacterial Membrane Lipids And Liposomal Compounds Integrating Such Compounds |
| 09/17/2009 | US20090232879 Thyromimetics for the Treatment of Fatty Liver Diseases |
| 09/17/2009 | US20090232878 Artificial Skin Substitute |
| 09/17/2009 | US20090232877 Method and composition for in situ formation and/or expansion of a polymer-based hemostatic agent to control bleeding |
| 09/17/2009 | US20090232876 Method and composition for in situ formation of an artificial blockage to control bleeding |
| 09/17/2009 | US20090232874 Fibrous membrane for biomedical application based on poly(ester-amide)s |
| 09/17/2009 | US20090232873 Personal Care Composition in the Form of an Article |
| 09/17/2009 | US20090232872 Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films |
| 09/17/2009 | US20090232871 Biocompatible polymers and co-polymers, and uses thereof |
| 09/17/2009 | US20090232870 Apparatus and method of retaining and releasing molecules from nanostructures by an external stimulus |
| 09/17/2009 | US20090232868 Nitric Oxide Releasing Polymer Composition |
| 09/17/2009 | US20090232866 Oligopeptides as coating material for medical products |
| 09/17/2009 | US20090232865 End-Capped Poly(Ester Amide) Copolymers |
| 09/17/2009 | US20090232864 Method for applying a bioactive, tissue-compatible layer onto shaped articles and the use of such shaped articles |
| 09/17/2009 | US20090232858 Method and process for the production of multi-coated recognitive and releasing systems |
| 09/17/2009 | US20090232857 Method and process for the production of multi-coated recognitive and releasing systems |
| 09/17/2009 | US20090232856 Stable three-phased emulsions |
| 09/17/2009 | US20090232855 Percutaneous controlled releasing material using nano-sized polymer particles and external application agent containing the same |
| 09/17/2009 | US20090232854 Uses of bispecific antibody coated dendritic cells pulsed with antigens and gm-csf in immune regulation |
| 09/17/2009 | US20090232853 Treatment of laminitis |
| 09/17/2009 | US20090232835 Composition for delivery of hematopoietic growth factor |
| 09/17/2009 | US20090232746 Silicone polymer-silica system |
| 09/17/2009 | US20090232745 Licorice lollipop that inhibits dental caries formation |
| 09/17/2009 | US20090232744 Macrolide compositions having improved taste and stability |
| 09/17/2009 | US20090232743 Foamable Microemulsion Compositions for Topical Administration |
| 09/17/2009 | US20090232738 Methods for modulating de novo hepatic lipogenesis by modulating XBP-1 activity |
| 09/17/2009 | US20090232731 Cationic Liposomal Preparations for the Treatment of Rheumatoid Arthritis |
| 09/17/2009 | US20090232730 Method of producing immunoliposomes and compositions thereof |
| 09/17/2009 | US20090229600 Method Of Forming An Aerosol For Inhalation Delivery |
| 09/17/2009 | DE102008014533A1 Gingival-Wafer Gingival wafer |
| 09/17/2009 | DE102008014237A1 Direktverpressbares Tablettierhilfsmittel Direktverpressbares tableting aids |
| 09/17/2009 | DE102008014109A1 Suspensionsformulierung für Kohlenstoff-Adsorbentien Suspension formulation for carbon adsorbents |
| 09/17/2009 | DE102008012295A1 Gemisch zur Herstellung von schnell zerfallenden Tabletten Mixture for the preparation of rapidly disintegrating tablets |
| 09/17/2009 | CA2720108A1 Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic |
| 09/17/2009 | CA2718345A1 Long-term stable pharmaceutical preparation having the active ingredient glycerol trinitrate |
| 09/17/2009 | CA2718262A1 Formulations of vitamin k analogs for topical use |
| 09/17/2009 | CA2718257A1 Drug delivery systems comprising weakly basic drugs and organic acids |
| 09/17/2009 | CA2718255A1 Solid dispersion and pharmaceutical composition of the same, and production processes thereof |
| 09/17/2009 | CA2718189A1 Nanoparticulate compositions of angiogenesis inhibitors |
| 09/17/2009 | CA2718161A1 Drug delivery to the anterior and posterior segments of the eye using eye drops |
| 09/17/2009 | CA2718142A1 Suspension formulation for carbon adsorbents |
| 09/17/2009 | CA2718028A1 Formulation and method for the prevention and treatment of bone metastases or other bone diseases |
| 09/17/2009 | CA2717984A1 Enhanced transmucosal composition and dosage form |
| 09/17/2009 | CA2717947A1 Orally-disintegrating solid preparation |
| 09/17/2009 | CA2717867A1 Activated nitric oxide donors and methods of making and using thereof |
| 09/17/2009 | CA2717494A1 Compressed tablets |
| 09/17/2009 | CA2717191A1 Transdermal therapeutic system having stabilized membrane |
| 09/17/2009 | CA2716724A1 Novel dosage and formulation |
| 09/17/2009 | CA2716723A1 Novel dosage and formulation |
| 09/17/2009 | CA2715585A1 Large particle size crystallised maltitol powder, method for preparing same and applications thereof, particularly in chocolate production |
| 09/16/2009 | EP2100915A1 Process for production of porous body and uses thereof |
| 09/16/2009 | EP2100914A1 Method for producing modified biopolymer and method for crosslinking biopolymers |
| 09/16/2009 | EP2100620A1 Nucleic acids encoding polyepitope polypeptides |
| 09/16/2009 | EP2100616A2 Composition of antigen and glycolipid adjuvant sublingual administration |
| 09/16/2009 | EP2100612A2 Semi-solid mucoadhesive formulations |
| 09/16/2009 | EP2100610A1 Pharmaceutical composition containing low-substituted hydroxypropylcellulose |
| 09/16/2009 | EP2100609A1 Solid medicinal preparation containing mannitol or lactose |
| 09/16/2009 | EP2100608A1 Method for producing solid preparation |
| 09/16/2009 | EP2100607A1 Pharmaceutical composition having improved storage stability |
| 09/16/2009 | EP2100606A1 Film-coated preparation having improved stability |
| 09/16/2009 | EP2100601A2 Topical pharmaceutical foam composition |
| 09/16/2009 | EP2100600A1 Extended release oral dosage composition |
| 09/16/2009 | EP2100599A1 Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
| 09/16/2009 | EP2100598A1 Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
| 09/16/2009 | EP2100597A2 Liposome complexes |
| 09/16/2009 | EP2100596A2 Injectable liquid paracetamol formulation |
| 09/16/2009 | EP2100595A1 Compressed tablets |
| 09/16/2009 | EP2099492A2 Duloxetine composition |
| 09/16/2009 | EP2099485A1 Alphavirus and alphavirus replicon particle formulations and methods |
| 09/16/2009 | EP2099449A1 Pharmaceutical composition for the treatment and prevention of diseases involving impotence |
| 09/16/2009 | EP2099448A1 Pharmaceutical composition for treatment and prevention of restenosis |
| 09/16/2009 | EP2099437A2 Porous keratin construct and method of making the same |
| 09/16/2009 | EP2099436A1 Microdevice and method for transdermal delivery and sampling of active substances |
| 09/16/2009 | EP2099435A2 Film-coated solid dosage form |
| 09/16/2009 | EP2099434A2 Devices, systems and methods for medicament delivery |
| 09/16/2009 | EP2099433A2 Modified release ibuprofen solid oral dosage form |
| 09/16/2009 | EP2099432A2 Method of forming a tablet comprising pre-blend of ibuprofen and silicon dioxide |
| 09/16/2009 | EP2099431A2 Stabilized solid pharmaceutical composition of candesartan cilexetil |
| 09/16/2009 | EP2099430A2 Ph sensitive matrix formulation |
| 09/16/2009 | EP2099429A2 Micellar nanoparticles comprising botulinum toxin |
| 09/16/2009 | EP2099410A2 Compositions comprising macromolecular assemblies of lipid and surfactant |
| 09/16/2009 | EP2099408A2 Fluoropolymer-based emulsions for the intravenous delivery of fluorinated volatile anesthetics |
| 09/16/2009 | EP2099387A2 Intraocular drug delivery systems |
| 09/16/2009 | EP1893237B1 Pharmaceutical composition comprising an organopolysiloxane elastomer and a solubilized active principle |
| 09/16/2009 | EP1752142B1 Pegylated nanoparticles |
| 09/16/2009 | EP1684728B1 Non-effervescent form of sodium naproxen comprising i.a. sodium hydrogen carbonate |
| 09/16/2009 | EP1666557B1 Heating element including a hot melt adhesive |
| 09/16/2009 | EP1631252B1 Method for producing a solid pharmaceutical composition |
| 09/16/2009 | EP1525283B1 Use of a block copolymer comprising at least one hydrophilic block |
| 09/16/2009 | EP1519748B1 Microparticle with cd28-specific monoclonal antibodies |
| 09/16/2009 | EP1324776B1 Reduced-viscosity concentrated protein formulations |
| 09/16/2009 | EP1223978B9 Archaeosomes as adjuvants and carriers for acellular vaccines to induce cytotoxic t lymphocyte (ctl) responses |
| 09/16/2009 | EP1169021B1 Compositions and methods for treating lymphoma |
| 09/16/2009 | EP1153601B1 Skin preparations for external use |
| 09/16/2009 | EP0941087B1 Topical formulations containing as a therapeutic active agent a monoglyceride for treating of mucosa infections |
| 09/16/2009 | CN201308646Y Environment-friendly type plaster |
| 09/16/2009 | CN101534823A Oral care compositions containing combinations of anti-bacterial and host-response modulating agents |